What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Tirzepatide Updates

Diana Isaacs

Weightloss in Menopause

Susan Brian

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

Robert Busch

Diabetic Peripheral Neuropathy: A Review of Clinical Practice Guidel…

Michigan Medicine - Podiatry

G. Rothenberg